Stay updated on PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedUpdated to v3.0.2 (replacing v3.0.1); the Back to Top element was removed as a minor UI change.SummaryDifference0.1%
- Check11 days agoChange DetectedThe page has updated the status of a clinical trial from 'Recruiting' to 'Unknown status', indicating a significant change in the availability of participation. Additionally, the version number has been revised from v3.0.0 to v3.0.1.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several related medical topics and terms have been removed, including references to pembrolizumab and various cancer-related categories.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated to a new version (v2.16.11), and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
- Check55 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.